SCHEMBL17547007

SCHEMBL17547007

C=C(C)C(=O)Oc1ccc(-c2ccc(-c3ccc(OC(=O)C(=C)C)c(OC(=O)C(=C)CC)c3)c(F)c2)cc1OC(=O)C(=C)CC

nearest known ligand 0.36

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
GAPDH P04406 1/20 0.36
AKR1C3 P42330 5/20 0.33
AKR1C2 P52895 5/20 0.33
ADORA3 P0DMS8 2/20 0.33
ADORA2A P29274 1/20 0.33
PRKCZ Q05513 1/20 0.33
AKR1B10 O60218 1/20 0.32
AKR1C4 P17516 1/20 0.32
AKR1C1 Q04828 1/20 0.32
APP P05067 1/20 0.32
ALOX5AP P20292 1/20 0.32
FEN1 P39748 1/20 0.32
PTGS2 P35354 1/20 0.32
RARB P10826 1/20 0.32
PPARD Q03181 1/20 0.32
ALOX15 P16050 1/20 0.32
HTT P42858 1/20 0.32
CFD P00746 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15338821 0.91 GAPDH (0.41) GAPDHAKR1C3AKR1C2ADORA3ADORA2A
SCHEMBL15338898 0.90 GAPDH (0.40) GAPDHAKR1C3AKR1C2ADORA3ADORA2A
SCHEMBL22459602 0.88 GAPDH (0.34) GAPDHAKR1C3AKR1C2ADORA3ADORA2A
SCHEMBL22459246 0.88 GAPDH (0.34) GAPDHAKR1C3AKR1C2ADORA3ADORA2A
SCHEMBL15338894 0.87 APP (0.39) GAPDHAKR1C3AKR1C2ADORA3AKR1C4
SCHEMBL25933764 0.86 FGFR1 (0.40) AKR1C3AKR1C2PRKCZPTGS2ALOX15
SCHEMBL24440894 0.86 AMY1A (0.41) GAPDHAKR1C3AKR1C2PRKCZAPP
SCHEMBL18699583 0.86 AR (0.42) GAPDHAKR1C3AKR1C2PRKCZAPP
SCHEMBL21483025 0.85 ELANE (0.42) GAPDHAKR1C3AKR1C2ADORA3ADORA2A
SCHEMBL17589362 0.85 GAPDH (0.34) GAPDHADORA3ADORA2AALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3327045-A1 POLYMERIZABLE COMPOUND, POLYMERIZABLE COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE JNC Corporation (JP) 2018-05-30 EP disclosed
US-20160075950-A1 POLYMERIZABLE COMPOUND, POLYMERIZABLE COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE JNC CORPORATION (JP) 2016-03-17 US disclosed
EP-2990424-A1 POLYMERIZABLE COMPOUND, POLYMERIZABLE COMPOSITION, AND LIQUID CRYSTAL DISPLAY ELEMENT JNC Corporation (JP) 2016-03-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160075950-A1 POLYMERIZABLE COMPOUND, POLYMERIZABLE COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE PYM1, DRD1, PLD1 GAPDH 4797/4885AKR1C3 3335/4885AKR1C2 4054/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.